< PreviousSCIENTIFIC PROGRAMME30 Scientific Programme Overview Saturday, 15 April 2023 All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone. Hall MHall NHall OHall PArena 1Arena 2 08:30 – 10:3008:30 – 09:3008:30 – 10:3008:30 – 10:3008:30 – 09:30 SY003OS014SY004SY005EF015 How to deal with antibiotic allergy? Emerging and vaccine preventable bacteria across Europe Difficult-to-treat infections: the role of bacterialbiofilmand persisters Human animal interface: chasing Echinococcus Bacteria in the soft tissue and bone 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 OS031ME027OS032OS033EF034 Diagnostic, therapeu- tic and prophylactic strategies in herpes- viruses infections Antifungal dose optimisation: from theory to clinical practice The expanding use of phages as therapeutics Intracellular bacterial infections and persistence Resistance to novel antibiotics and beta- lactamase inhibitors 13:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:30 OS045OS046OS047SY042EF048 Towards improving genomic and environmental surveillance of SARS- CoV-2 Artificialintelligence becoming natural in infectious disease diagnostics Pharmacokinetics, also important for fungal infection treatment Restoring healthy microbiota Antibiotic stewardship: anything you always wanted to know 14:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:45 OS060ME055ME056ME057EF061 Epidemiology and management of prosthetic joint infections Diphtheria: an ancient scourge with global presence Implementation of tuberculosis genomics in clinical practice Doing more with less: improving laboratory quality for AMR surveillance with limited resources Antibiotic resistance in sexually transmitted infections 16:15 – 18:1516:15 – 17:1516:15 – 18:1516:15 – 18:1516:15 – 17:15 EW067OS072SY066OS071EF073 Host-pathogen interactions and immunotherapies in infectious diseases TAE Research BitesHIV-associated fungal infections: the stateofthefield Pathogenesis and therapeutic targeting of bacterial and biofilm-associated infections Urinary tract infections: diagnostic and treatment issues 17:15 – 18:15 EF075 Resistance in fungi: a movingfield 09:30 – 10:30 EF017 Critical issues of COVID-19 in immuno- deficientpatientsFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202331 Arena 3Arena 4 08:30 – 09:30 EF016 Down the drain: infection control and the environment 11:00 – 12:00 EF035 Improving bloodstream infection diagnostics 12:15 – 13:15 EF036 There is no planet B: sustainability in ID/CM 13:30 – 14:30 EF049 New insights in Clostridioides difficile: from pigs to poo 14:45 – 15:45 EF062 Tropical pearls 16:15 – 17:15 EF074 Critically ill COVID-19 patients: still room to understand vulnerability and improve outcome 17:15 – 18:15 EF076 Viral infections across the globe Colour Key Educational Workshops, Meet-the-Expert SessionsSymposia (1h/2h)Oral sessions (1h/2h) Keynote Lectures Open Forum & ePoster Flash SessionTAE Day Integrated Symposia & Pipeline Corners are not detailed in this book. Please refer to the Industry Guide for session details. 09:30 – 10:30 EF018 How to improve thera- peutic options: insight into mechanisms and development of novel antimicrobial compoundsSCIENTIFIC PROGRAMME32 Scientific Programme Overview Sunday, 16 April 2023 Hall AHall BHall CHall DHall EHall F 08:30 – 10:3008:30 – 10:3008:30 – 10:30 OS082OS083IS16 New vaccines in clinical development Diagnosis and management of refractory and rare moulds: a case-based approach (Re-)emerging zoonotic and vector- borne diseases 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 KN091ME098OS102OS103SY092OS104 A revolution in the management of cryptococcal meningitis Paediatric interactive cases: dilemmas for the microbiologist and infection specialist More speed in microbiological testing Difficult-to-manage CNS infections What can be learned from successful vertical programs to mitigate AMR Virulent viruses 12:15 – 13:1512:15 – 13:1512:15 – 13:15 IS19IS20IS21 The value of diagnostic information for antimicrobial stewardship COVID-19 today: optimizing outpatient management Keeping pace with SARS-CoV-2: ongoing considerations for COVID-19 management 13:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 15:3013:30 – 15:3013:30 – 15:30 SEL1SY110SY111IS24IS25IS26 Selective Pressure: Quiz Show - Pre-round Antigen testing vs RT-PCR for viral respiratory tract infections Effects of viruses on the central nervous system Chasing variants? Future of COVID-19 prevention in the EU Pneumococcal disease in adults: current challenges and new paradigms for prevention Optimising the treatment of invasive fungal infections: spotlight on evolving epidemiology and the current diagnostic landscape 14:45 – 15:4514:45 – 15:4514:45 – 15:45 SEL2ME125SY122 Selective Pressure: QuizShow-Semi-final andfinal How to make sure my MALDI is doing a good job? ESCMID guidelines on diagnosis and treatment of brain abscess 16:15 – 17:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:15 KN134OS142SY135IS29IS30IS31 Urinary tract infections: from fundamental bench science to translatable therapeutics A genomic view of the evolution and spread of carbapenem- resistant Enterobacterales Viral infections in immunosuppressed patients: what is new? Integrated approach- es to accelerate and improve diagnostics in microbiology Infectious disease rounds: case-based discussion of incor- porating new data managing CMV and Gram-negative in- fections into clinical practice AMR, sustainabili- tyandefficiency: 'Staying ahead of tomorrow's challeng- es, today' All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone.FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202333 Hall GHall HHall IHall JHall KHall L 08:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:30 IS17IS18EW079SY077OS084SY078 Molecular diagnostics for various infectious diseases and their usability through actual test performance Preventing influenzaandits complications: why randomised studies matter Improving indoor ventilation in healthcare environments AMR and adaptive mechanisms in per- sistentcysticfibrosis infection Late-breaking trial results for COVID and other viral infections Fairytales or reality, checking some eminence paradigms for treatment of severe infections 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 SY093SY094ME099SY095SY096OS105 When a microbe turns the body against itself: enteroviruses and autoimmunity Inborn errors of im- munity, COVID-19 and beyond: determinants of host immunity to infectious diseases Why is it still so complex? How I treat persistent neutro- paenic fever It's all about the U bend Year in infectious disease Late breaker: new mechanisms, new agents 12:15 – 13:1512:15 – 13:15 IS22IS23 Sample collection: needs, challenges, and future Building a strong de- fense: addressing the importance of adult vaccination in the evolving pneumococ- cal disease landscape 13:30 – 15:3013:30 – 15:3013:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:30 IS27IS28OS115OS116SY112OS117 Potential role of the mRNA platform for infectious diseases Providing expert consultation in a world living with COVID-19 Recently approved antibacterials in real life Viral hepatitis epidemiology to prevention Innovative trial design and new drugs/regimens for tuberculosis: current update and management impact Using omics approaches to study AMR 14:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:45 OS127OS128SY123OS129 Challenges and advances in skin, soft tissue, bone and joint infections Particularities of paediatric COVID: from molecular diagnosis to therapeutic response New antibiotics: from early discovery to bedside Novel resistance mechanisms 16:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:15 IS32IS33EW140SY136SY137SY138 Next generation sequencing in routine use for all clinical microbiology laboratories: this is now! Get smart in invasive mould disease (IMD) management Basic microbiology for infectious disease doctors: indications, preanalytics, meth- ods and pitfalls Tacklinginfluenza and RSV management in the post-COVID era Sepsis: present and future considerations in management Clostridioidies difficile infection, to bacteria and beyond All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone. Colour Key Educational Workshops, Meet-the-Expert SessionsSymposia (1h/2h)Oral sessions (1h/2h) Keynote Lectures Open Forum & ePoster Flash SessionTAE Day Integrated Symposia & Pipeline Corners are not detailed in this book. Please refer to the Industry Guide for session details.SCIENTIFIC PROGRAMME34 Scientific Programme Overview Sunday, 16 April 2023 All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone. Hall MHall NHall OHall PArena 1Arena 2 08:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 09:30 EW080OS085EW081OS086EF087 Software makes the lab go round: laboratory informa- tion management software (LIMS) revisited Resistance epidemi- ology in a One Health perspective Beyond toxic: immunomodulatory roles of bacterial toxins New trends in staphylococcal infections MRSA: still an import- ant pathogen 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 ME100SY097ME101OS106 New imaging methods in infective endocarditis Therapy optimisation of antiviral drugs Data analyses of microbiota data: what is state of the art and what can be expected? Management of infections in low- and middle-income settings 12:15 – 13:15 FO108 Equal opportunity in publication and research? 13:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:30 ME113OS118OS119ME114EF120 Tropical and travel medicine: a case- based approach Management of endocarditis caused by unusual microorganisms Diagnosis of bloodstream infections and sepsis How to set up a phage therapy centre Update on TB basic and clinical research, 2023 14:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:45 SY124ME126OS130OS131EF132 Learning from the past: paleomicrobiology How do I deal with patients having suspected BSL-3/ BSL-4 micro- organism? Innovative diagnostic approaches for fungal infections Anti-virulence targets at the bacterial surface Gastrointestinal and abdominal infections: epidemiology to management 16:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 17:15 OS143SY139OS144EW141EF145 How good are the COVID-19 vaccines? Neglected tropical skin diseases Clinical PK/PD studies to improve dosing Adding a twist to the tail: update on spirochaetes of medical and veterinary importance AMR in LMICs 17:15 – 18:15 EF147 Using sequencing to trace SARS-CoV-2 09:30 – 10:30 EF089 Antibiotic steward- ship around the globeFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202335 Arena 3Arena 4 08:30 – 09:30 EF088 Around the world in 60 minutes with COVID 11:00 – 12:00 EF107 Diagnosis of infections in LMIC including tuberculosis 12:15 – 13:15 FO109 Developing your funding application: from drug discovery to drug development 13:30 – 14:30 EF121 Fungal infection treatment around the world 14:45 – 15:45 EF133 Seasonal respiratory virus: a continued challenge 16:15 – 17:15 EF146 Infection control and COVID-19 17:15 – 18:15 EF148 Bacterial virulence from bench to bedside Moche Room 08:00 – 12:00 TAE001 TAE Day Colour Key Educational Workshops, Meet-the-Expert SessionsSymposia (1h/2h)Oral sessions (1h/2h) Keynote Lectures Open Forum & ePoster Flash SessionTAE Day Integrated Symposia & Pipeline Corners are not detailed in this book. Please refer to the Industry Guide for session details. 09:30 – 10:30 EF090 Intestinal pathogens: old problems, new challengesSCIENTIFIC PROGRAMME36 Scientific Programme Overview Monday, 17 April 2023 Hall AHall BHall CHall DHall EHall F 08:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:30 SY149SY150SY151IS34IS35 Responsible publishing in CM/ID Point of care diagnostics for detection of respiratory viruses and monkeypox Democratising genomic applications in clinical microbiology research with nanopore sequencing technology Measuring the changing threat of COVID-19: a view from four continents Neisseria meningitidis: from worldwide epidemiology to national vaccination policies 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 KN164ME172ME173SY165SY166OS175 Mitigation of rotavirus: current and future When an entire country is a cohort: harnessing epi and micro data Managing multidrug- resistant Candida infections Health problems of the largest wave of war refugees in mod- ern history in Europe Chlamydia: from the epidemiology to the clinics Immune protection in vulnerable populations 12:15 – 13:1512:15 – 13:1512:15 – 13:15 IS37IS38IS39 How can we optimise the management of critically ill patients with CRE-KPC infec- tions: from clinical tri- als to clinical practice BacteriologIA: ArtificialIntelligence applied to bacteri- ology Building towards understanding the burden of RSV lower respiratory tract infection in older adults 13:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 15:3013:30 – 15:3013:30 – 15:30 KN184ME188OS191IS42IS43IS44 The role of the archaeome: composition and function in human health and disease How to set up in house qPCR assays for rare pathogens? New developments in bacterial CNS infections C. difficile infection: targeting an unwelcome and persistent threat Diagnostics in the post-COVID-19 era: variants, superbugs and future pandemics Adults at risk of infectious diseases: understanding prevention options and gaps 14:45 – 15:4514:45 – 15:4514:45 – 15:45 KN197ME201OS203 Structural determinants of health:howscientific societies can influencechange New drugs for respi- ratory viruses in the immunosuppressed: not only SARS-CoV-2 please... Rapid phenotypic AST for Gram-negative rod 16:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:15 SY210EW215IS47IS48IS49 17:15 – 18:15Expanding global access to diagnostics Communication, team dynamics, and patient involvement in antimicrobial stewardship Spanning the diag- nostics portfolio: an in depth look at out- comes and use cases benefittingdifferent patient populations Facing a new era in infectious disease control: unlocking complexity with molecular syndromic multiplex testing Success in managing CA-RTIs and reducing antimicrobial resis- tance: can both be achieved? SY222 Expanding genomic sequencing capacity globally to enhance epidemic surveillance and response All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone.FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202337 Hall GHall HHall IHall JHall KHall L 08:30 – 10:3008:30 – 09:3008:30 – 10:3008:30 – 10:3008:30 – 10:30 IS36SY155SY152EW156SY153 Next-generation vaccineinthefight against COVID-19 Clinical Microbiology and Infection: COVID-19 research that matters Point-of-Care testing (POCT): impact and challenges All for one and one for all! Prevention, diagnostic, and antibiotic stewardship to reduce the burden of AMR: guidance in real cases Antimicrobial stewardship in special populations 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 SY167OS176OS177SY168SY169SY170 Strengthening laboratory systems in Africa Digital applications for participatory infection surveillance Cutting edge in respiratory bacterial infections Personalised prevention and control of HAIs in the ICU Year in clinical microbiology Phage therapy: countering resistance development 12:15 – 13:1512:15 – 13:15 IS40IS41 The uUTI paradox: appropriate antibi- otics use in empiric setting? Harnessing data to support clini- cal practice The value of the syndromic approach for testing respiratory tract infections at point of care 13:30 – 15:3013:30 – 15:3013:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:30 IS45IS46SY185OS192SY186SY187 STI testing in the next decade Transforming care in the prevention and treatment of COVID-19 Viral hepatitis elimination: implications of the new roadmap New interventional trials in infection control Year in public healthThe use and misuse of MICs in patient management 14:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:45 OS204SY198SY199OS205 Mpox: lessons learntWHO AMR Impact Ini- tiatives and Research Coordination: WHO 2022 Bacterial Priority Pathogens List (BPPL) Hot topics in hepatitis B and D infections Take home antimicrobial stewardship interventions 16:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:15 IS50IS51SY211SY212SY213OS218 Disruptive innovations in the sepsis patient pathway and the impact on antibiotic stewardship Past and future of RSV: where are we now? Late-breaking research from The Lancet group New and old staphylococci Pending challenges in contemporary HIV care Metagenomic testing to improve laboratory diagnostics for infectious diseases All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone. Colour Key Educational Workshops, Meet-the-Expert SessionsSymposia (1h/2h)Oral sessions (1h/2h) Keynote Lectures Open Forum & ePoster Flash SessionTAE Day Integrated Symposia & Pipeline Corners are not detailed in this book. Please refer to the Industry Guide for session details.SCIENTIFIC PROGRAMME38 Scientific Programme Overview Monday, 17 April 2023 Hall MHall NHall OHall PArena 1Arena 2 08:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 10:3008:30 – 09:30 SY154OS158OS159EW157EF160 TB infection screen- ing and preventive therapy in high- and low-endemic settings Last line antibiotics against pan-drug resistant Gram- negative bacteria Endocarditis update 2023 Understanding molecular diagnostics in mycology: from standardisation to guidelines Age-related susceptibility to COVID and risks in long-term facilities 11:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:0011:00 – 12:00 OS178SY171ME174OS179EF180 Bone and prosthetic joint infections: addressing diagnostic challenges Ethical dilemmas with antimicrobial therapy How to incorporate gender in AMR Puzzling parasitesOld antibiotics used for MDR Gram- negative infections 12:15 – 13:15 FO182 Adaptive platform tri- als after the COVID-19 pandemic 13:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:3013:30 – 14:30 OS193ME189ME190OS194EF195 NTMs keep surprising us! The hopes and hurdles in the prevention and treatment of SSI in orthopaedic surgery and traumatology Easy to miss parasitic diseases in non-endemic settings Impact of host and pathogen genetics in fungal infections New insights in sepsis 14:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:4514:45 – 15:45 OS206SY200ME202OS207EF208 Non-canonical approaches to treatment of infections Sex matters for infection outcomes Secondary haemophagocytic lymphohistiocytosis and infectious diseases Bewildering bacteriaEpidemiology of fungal infections: a changing scenario 16:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 18:1516:15 – 17:15 SY214EW216EW217OS219EF220 Post-infective fatigue syndromes and long COVID: similarities and differences Are we having any impact? Monitoring guidelines implemen- tation and impact in practice Scaling up AMR interventions with stakeholders: diversity, equity and inclusion Do we trust the results of new diag- nostic technologies for the treatment of respiratory infec- tions? Non-tuberculous mycobacteria: from epidemiology to new drugs 17:15 – 18:15 EF223 Enterococcus spp.: still an important pathogen 09:30 – 10:30 EF162 Vector-borne diseases All times are specified in CEST (UTC +2). If attending online, please convert to your local timezone.FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202339 Arena 3Arena 4 08:30 – 09:30 EF161 Changing viral epide- miology 11:00 – 12:00 EF181 Infection against infections: innovative studies with phages 12:15 – 13:15 FO183 Gamification and simulated environments in CM/ ID education 13:30 – 14:30 EF196 New diagnostic tools for respiratory infections 14:45 – 15:45 EF209 Novel and possible future diagnostic markers for SARS- CoV-2 infection 16:15 – 17:15 EF221 Antimicrobial resistant organisms: surveillance and epidemiology Colour Key Educational Workshops, Meet-the-Expert SessionsSymposia (1h/2h)Oral sessions (1h/2h) Keynote Lectures Open Forum & ePoster Flash SessionTAE Day Integrated Symposia & Pipeline Corners are not detailed in this book. Please refer to the Industry Guide for session details. 09:30 – 10:30 EF163 Outbreaks: early recognition and diagnosisNext >